Aytu Biopharma, Inc. AYTU
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.00% | 47.00% | 47.20% | 62.27% | 54.71% |
| Total Receivables | -26.88% | -31.64% | 21.73% | 43.46% | 32.43% |
| Inventory | -40.00% | -32.54% | -21.91% | -13.96% | -5.82% |
| Prepaid Expenses | 3.12% | 16.17% | 7.62% | -10.08% | 10.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -22.00% | -7.15% | 20.92% | 33.54% | 27.93% |
|
|
|||||
| Total Current Assets | -22.00% | -7.15% | 20.92% | 33.54% | 27.93% |
| Net Property, Plant & Equipment | -22.03% | -20.52% | -14.82% | -21.23% | 4.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.89% | -12.77% | -12.77% | -19.09% | -19.55% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -50.08% | -57.91% | -51.51% | -52.36% | -45.98% |
| Total Assets | -15.44% | -10.07% | 4.97% | 7.91% | 5.15% |
|
|
|||||
| Total Accounts Payable | 6.44% | 9.74% | 21.88% | -8.67% | 2.78% |
| Total Accrued Expenses | -7.09% | -24.01% | -15.92% | -17.00% | -31.43% |
| Short-term Debt | -32.98% | 3.82% | 126.20% | 248.31% | 278.41% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.21% | 5.10% | 0.78% | -12.05% | -22.38% |
| Total Finance Division Other Current Liabilities | -19.51% | -28.09% | -11.22% | -5.02% | 5.88% |
| Total Other Current Liabilities | -19.51% | -28.09% | -11.22% | -5.02% | 5.88% |
| Total Current Liabilities | -13.33% | -15.18% | 2.37% | 7.74% | 1.34% |
|
|
|||||
| Total Current Liabilities | -13.33% | -15.18% | 2.37% | 7.74% | 1.34% |
| Long-Term Debt | -16.47% | 0.15% | 0.15% | 0.16% | 0.17% |
| Short-term Debt | -32.98% | 3.82% | 126.20% | 248.31% | 278.41% |
| Capital Leases | -13.40% | -8.19% | -12.03% | -10.58% | 70.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -83.08% | -24.25% | 202.81% | 84.79% | 81.27% |
| Total Liabilities | -33.72% | -14.29% | 26.14% | 18.38% | 16.41% |
|
|
|||||
| Common Stock & APIC | 8.67% | 9.84% | 2.26% | 1.84% | 1.38% |
| Retained Earnings | -4.27% | -10.86% | -7.69% | -4.10% | -4.24% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 85.99% | 0.70% | -53.84% | -22.31% | -31.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 85.99% | 0.70% | -53.84% | -22.31% | -31.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 85.99% | 0.70% | -53.84% | -22.31% | -31.57% |
|
|
|||||